BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 22, 2004
View Archived Issues
Arena Forms Deal Worth Up To $612M With Ortho-McNeil
Arena Pharmaceuticals Inc. takes a case-by-case approach when it comes to partnering its drug candidates. If the economics are right, the San Diego-based company will sign on the dotted line. (BioWorld Today)
Read More
Vicuron's NDA For Antibiotic Dalbavancin In FDA's Hands
Read More
Receptors, Signal Transduction Determine Range Of Viral Host
Read More
CAT Wins Court Battle Over Humira; Abbott Logs Appeal
Read More
Cell Therapeutics Raises $18.5M, Forms Quintiles Trisenox Deal
Read More
Other News To Note
Read More